[1] |
KNIPSCHEER P, RÄSCHLE M, SMOGORZEWSKA A, et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair[J]. Science,2009,326(5960):1698-1701.
|
[2] |
WU Y, BROSH RM JR.FANCJ helicase operates in the Fanconi anemia DNA repair pathway and the response to replicational stress[J]. Curr Mol Med,2009, 9(4):470-482.
|
[3] |
LIM SL, SMITH P, SYED N, et al.Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer[J]. Br J Cancer,2008, 98(8):1452-1456.
|
[4] |
AN J, WEI Q, LIU Z, et al.Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis[J].Int J Mol Epidemiol Genet,2010, 1(1):1-10.
|
[5] |
PAREDES J, ALBERGARIA A, OLIVEIRA JT, et al.P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation[J]. Clin Cancer Res, 2005, 11(16):5869-5877.
|
[6] |
NASS SJ, HERMAN JG, GABRIELSON E, et al.Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer[J]. Cancer Res, 2000, 60(16):4346-4348.
|
[7] |
CHEN H, HARDY TM, TOLLEFSBOL TO.Epigenomics of ovarian cancer and its chemoprevention[J]. Front Genet,2011, 2:67.
|
[8] |
ZHAO L, LI N, YU JK, et al.RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells[J]. Braz J Med Biol Res,2014,47(1):24-34.
|
[9] |
FABIANI E, LEONE G, GIACHELIA M, et al.Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia[J]. Leuk Lymphoma,2010, 51(12):2275-2284.
|